Type 2 Diabetes Mellitus
10 competing products in clinical development for Type 2 Diabetes Mellitus.
Pipeline by Phase
Phase 12
Phase 1/21
Phase 21
Phase 31
Approved5
All Products (10)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Insulin Lispro Mix25 + Insulin Lispro Mix50 | Eli Lilly | Approved | Completed | 85 |
| exenatide and sitagliptin + exenatide and placebo | Eli Lilly | Approved | Completed | 85 |
| Insulin Analog Mid Mixture + Basal Insulin Analog | Eli Lilly | Approved | Completed | 85 |
| Insulin Glargine | Eli Lilly | Approved | Completed | 85 |
| add-on pioglitazone + add-on sulphonylurea | AMD Biotech | Approved | UNKNOWN | 77 |
| exenatide once weekly + insulin detemir | Eli Lilly | Phase 3 | Completed | 77 |
| exenatide + Placebo | Eli Lilly | Phase 2 | Completed | 52 |
| exenatide once weekly + exenatide once weekly | Eli Lilly | Phase 1/2 | Completed | 41 |
| Retatrutide + Placebo | Eli Lilly | Phase 1 | Active | 33 |
| BioChaperone insulin lispro + Humalog® | Eli Lilly | Phase 1 | Completed | 33 |